Phosphorus-32: the forgotten radiopharmaceutical?

Nuclear Medicine Communications

Volumn 29, Issue 2, 2008, Pages 95-97

  Vinjamuri, Sobhan ^a   Ray, Soumendranath ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIHISTAMINIC AGENT; DYSPROSIUM 65; ERBIUM 169; ETIDRONIC ACID RE 186; HOLMIUM 166; HYDROXYUREA; PHOSPHATE P 32; PHOSPHORUS 32; RADIOPHARMACEUTICAL AGENT; RHENIUM 86; SAMARIUM 153; STRONTIUM 89; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG; YTTRIUM 90;

ARTHROPATHY; BONE MARROW TOXICITY; BONE METASTASIS; BONE PAIN; BREAST CANCER; BREMS RADIATION; CELL PROLIFERATION; DRUG CYTOTOXICITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; EDITORIAL; ERYTHROCYTOSIS; EXTRAMEDULLARY HEMATOPOIESIS; GAMMA RADIATION; HUMAN; HYPERURICEMIA; MYELOPROLIFERATIVE DISORDER; OPTIMAL DRUG DOSE; OSTEOCLAST; PHLEBOTOMY; PHOTON; PIGMENTED VILLONODULAR SYNOVITIS; POLYCYTHEMIA VERA; PROSTATE CANCER; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIORTHESIS; TREATMENT RESPONSE;

BONE NEOPLASMS; CLINICAL TRIALS AS TOPIC; GREAT BRITAIN; HUMANS; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; NUCLEAR MEDICINE; PHOSPHORUS RADIOISOTOPES; POLYCYTHEMIA VERA; RADIOPHARMACEUTICALS;

EID: 37349089032     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f1d4eb     Document Type: Editorial

References (10)

1. Merters WC. Radionuclide therapy of bone metastases: prospects for enhancement of therapeutic efficiency. Semin Oncol 1993; 20 (Suppl 2):49-55.
2. Navarro-Izquierdo AL, Baringo T, Dominguez J, Duque JJ, Martinez Comin L, Solsona F. Metabolic curietherapy with P-32 in bone metastases with breast cancer. Rev Esp Oncol 1980; 27:101-106.
3. Cheung A, Driedger AA. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate. Radiology 1980; 134:209-212.
4. Kresnik E, Mikosch P, Gallowitsch HJ, Jesenko R, Just H, Kogler D, et al. Clinical outcome of radiosynoviorthesis: a meta analysis including 2190 treated joints. Nucl Med Commun 2002; 23:683-688.
5. Ariel IM, Hassouna H. Carcinoma of the prostate: the treatment of bone metastases by radioactive phosphorus (32P). Int Surg 1985; 70:63-66.
6. Berlin NI. Treatment of myeloproliferative disorders with P-32. Eur J Haematol 2000; 65:1.
7. Dunn AL, Manco Johnson M, Busch MT, Balark KL, Abshire TC. Metaanalysis of 2190 treated joints with P-32. J Thromb Haemost 2005; 3:1541-1542.
8. Tulchinsky M, Eggli D. Intraperitoneal distribution imaging prior to chromic phosphate therapy in ovarian cancer patients. Clin Nucl Med 1994; 19:43-48.
9. Dunn AL, Manco-Johnson M, Busch MT, Balark KL, Abshire TC. Leukemia and P32 radionuclide synovectomy for hemophilic arthropathy. J Thromb Haemost 2005; 3:1541-1542.
10. Fischer M, Modder G. Radionuclide therapy of inflammatory joint diseases. Nucl Med Commun 2002; 23:829-831.